Filing Details
- Accession Number:
- 0001567619-19-001770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-28 15:45:12
- Reporting Period:
- 2019-01-24
- Accepted Time:
- 2019-01-28 15:45:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70487 | National Research Corp | NRC | Services-Commercial Physical & Biological Research (8731) | 470634000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579448 | 10/24/18 Agreement Under Trust K/I/E | Bessemer Trust Company Of Delaware, N.a. 1007 N. Orange St., Suite 1450 Wilmington DE 19801 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-24 | 4,148 | $40.00 | 5,175,565 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-25 | 5,582 | $40.01 | 5,169,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.025. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $40.00 to $40.14. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Billionaire Hedge Funds
